Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc., et al.
Case Number:
1:14-cv-01268
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 15, 2016
Takeda IP Suit Over Hikma Gout Flare Drug Is Reopened
A Delaware federal judge has reopened Takeda Pharmaceuticals USA Inc.'s suit accusing West-Ward Pharmaceutical Corp. and parent Hikma Pharmaceuticals PLC of infringing five patents through competing gout flare drug Mitigare, ruling Wednesday that a second amended complaint contains sufficiently detailed allegations.
-
May 18, 2016
Takeda's Suit Targeting Rival Gout Drug Is Dismissed
A Delaware federal judge on Wednesday tossed Takeda Pharmaceuticals USA Inc.'s suit accusing West-Ward Pharmaceutical Corp. and parent Hikma Pharmaceuticals PLC of infringing its patents through the competing gout drug Mitigare, saying the rival's label doesn't directly address Takeda's patented methods.